Email ephwyi@nus.edu.sg

Dr WANG Yi’s research areas include early health technology assessment, traditional health technology assessment, population’s preference for health and healthcare, and economic evaluation/analysis using real-world data and observational data. He is also interested in medical innovation and promoting efficient medical innovation process.

• NUS Saw Swee Hock School of Public Health

• Health economics
• Health technology assessment
• Early health technology assessment
• Consumers’/patients’ preference and decision making
• Real-world data, real-world evidence

• Public health economics
• Health econometrics
• Health technology assessment
• Early health technology assessment

• Ph.D. Economics, National University of Singapore, 2017
• B.A. Science in Mathematics & Economics, Nanyang Technological University, 2012. with First class honours

• 08/2012 – 08/2016 President Graduate Fellowship, National University of Singapore
• 12/2006 – 05/2012 PRC Undergraduate Scholarship
• Sem 2, AY 14/15 Nominee for Best Teaching Award

• Feb 2021 to Jan 2023: Senior Research Fellow, Saw Swee Hock School of Public Health, National University of Singapore
• Nov 2020 to May 2021: Visiting Researcher, Health Intervention and Technology Assessment Program, Thailand
• Jul 2019 to Jan 2021: Research Fellow, Saw Swee Hock School of Public Health, National University of Singapore
• Jul 2017 to Jun 2019: Postdoctoral Fellow, Saw Swee Hock School of Public Health, National University of Singapore
• Aug 2016 to Jun 2017: Teaching Assistant, Department of Economics, National University of Singapore

• Wang Y, Low FZ, Low YY, Lai HS, Lim JH, Yeow CH, Teerawattananon Y. Using Early Health Economic Modelling to Inform Medical Innovation Development: A Soft Robotic Sock in Post-Stroke Patients in Singapore. International Journal of Technology Assessment in Health Care, 2023, 39(1), E4.
• Wang Y, Luangasanatip N, Pan–ngum W, Isaranuwatchai W, Prawjaeng J, Saralamba S, Painter C, Briones JR, Teerawattananon Y. Assessing the cost-effectiveness of COVID-19 vaccines in a low incidence and low mortality setting: the case of Thailand at start of the pandemic. The European Journal of Health Economics. 2022 Aug 11:1-4.
• Wang Y, Faradiba D, Del Rio Vilas VJ, Asaria M, Chen YT, Babigumira JB, Dabak SV, Wee HL. The relative importance of vulnerability and efficiency in COVID-19 contact tracing programmes: a discrete choice experiment. International journal of public health. 2022:134.
• Wang Y, Rattanavipapong W, Teerawattananon Y. Using health technology assessment to set priority, inform target product profiles, and design clinical study for health innovation. Technological forecasting and social change. 2021 Nov 1;172:121000.
• Tan RK, Wang Y, Prem K, Harrison-Quintana J, Teo AK, Kaur N, Cook AR, Mark I, Chen C, Wong CS. HIV Pre-Exposure Prophylaxis, Condoms, or Both? Insights on Risk Compensation Through a Discrete Choice Experiment and Latent Class Analysis Among Men Who Have Sex With Men. Value in Health. 2021 May 1;24(5):714-23.

View the full list of publications here.

View his detailed CV here.